1 day ago · Looks like they approved the two-dose 62% ~effective~ efficacy regiment. There was a lot of hope for the one-dose given the supply constraints or a retrial for the more promising half+full dose for greater efficacy.
1 day ago · Looks like they approved the two-dose 62% ~effective~ efficacy regiment. There was a lot of hope for the one-dose given the supply constraints or a retrial for the more promising half+full dose for greater efficacy.
1. Gary McKinnon 2. LulzSec 3. Adrian Lamo 4. Mathew Bevan and Richard Pryce 5. Jonathan James 6. Kevin Poulsen 7. Kevin Mitnick 8. Anonymous 9. Astra